Fulminant Diabetes in a Patient with Advanced Melanoma on Nivolumab.
Nora ChokrHafsa FarooqElizabeth GuadalupePublished in: Case reports in oncological medicine (2018)
Anti-PD-1 immunotherapy is effective in cancers refractory to standard chemotherapy. These agents can precipitate autoimmune disorders. As the use of anti-PD-1 agents is expected to rise, physicians should be educated about the potential side effects. We recommend conducting routine blood glucose checks in patients on these agents.
Keyphrases
- blood glucose
- end stage renal disease
- glycemic control
- type diabetes
- ejection fraction
- newly diagnosed
- primary care
- chronic kidney disease
- multiple sclerosis
- prognostic factors
- peritoneal dialysis
- case report
- squamous cell carcinoma
- clinical practice
- climate change
- risk assessment
- young adults
- drug induced
- weight loss
- patient reported
- human health